OR5K3 Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cromolyn disodium salt | 15826-37-6 | sc-207459 sc-207459A sc-207459B sc-207459C sc-207459D sc-207459E sc-207459F | 1 g 5 g 25 g 50 g 100 g 500 g 1 kg | $50.00 $174.00 $624.00 $1040.00 $1873.00 $2913.00 $3537.00 | ||
Cromolyn disodium salt inhibits the release of mediators from mast cells, which are involved in inflammatory pathways that Olfactory receptor 5K3 participates in. This inhibition can reduce the activation of Olfactory receptor 5K3 by limiting its ligand availability. | ||||||
Quinacrine, Dihydrochloride | 69-05-6 | sc-204222 sc-204222B sc-204222A sc-204222C sc-204222D | 100 mg 1 g 5 g 200 g 300 g | $46.00 $57.00 $87.00 $3257.00 $4821.00 | 4 | |
Quinacrine inhibits phospholipase A2 activity, thereby reducing the production of arachidonic acid, a precursor for inflammatory mediators that could activate Olfactory receptor 5K3, leading to its functional inhibition through decreased signaling. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $68.00 $267.00 | 10 | |
BAPTA chelates calcium ions, inhibiting calcium-mediated signaling pathways that Olfactory receptor 5K3 may rely on for its activation or function, thus indirectly inhibiting Olfactory receptor 5K3 by reducing its signaling capabilities. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 inhibits PI3K, a key enzyme in the phosphatidylinositol signaling pathway. This inhibition disrupts downstream signaling that could be crucial for Olfactory receptor 5K3 function, indirectly inhibiting its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 selectively inhibits MEK1, which is part of the MAPK/ERK pathway. Inhibition of this pathway can indirectly inhibit Olfactory receptor 5K3 by disrupting signaling processes that may be essential for its activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 203580 inhibits p38 MAP kinase, a protein involved in inflammatory and stress response pathways. By inhibiting p38 MAP kinase, SB 203580 can indirectly inhibit Olfactory receptor 5K3 activity linked to these responses. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which is involved in stress and inflammatory signaling pathways. Inhibition of JNK can lead to reduced activity of Olfactory receptor 5K3 by affecting signaling pathways it participates in. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
W-7 inhibits calmodulin-dependent processes, which can indirectly inhibit Olfactory receptor 5K3 by disrupting calcium signaling pathways necessary for its function, leading to a decrease in Olfactory receptor 5K3 signaling capabilities. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib inhibits EGFR tyrosine kinase, which could indirectly inhibit Olfactory receptor 5K3 by disrupting EGFR-mediated signaling pathways that may cross-talk with pathways involving Olfactory receptor 5K3, thus reducing its activity. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
Lapatinib inhibits HER2 and EGFR, tyrosine kinases involved in signaling pathways that could intersect with Olfactory receptor 5K3 pathways, indirectly inhibiting its function by reducing signaling through these pathways. | ||||||